Abstract
Several earlier studies have implicated platelet activation with the pathogenesis of thrombotic stroke. In this report we have studied the changes in membrane physical microenvironment and signal transduction in the platelets obtained from the patients with thrombotic stroke. Aggregation induced by the synthetic agonist thrombin receptor-activating peptide was significantly enhanced (p < 0.001) in the platelets obtained from the patients. Steady-state fluorescence anisotropy measurements using diphenylhexatriene reflected a significant increase in membrane microviscosity from 3.315 (± 0.103) in the control to 4.600 (± 0.119) in the stroke. Proteins of relative mobilities of 131, 100, 47 and 38 kDa were found to remain phosphorylated on tyrosine in the resting platelets obtained from thrombotic stroke patients while they were not phosphorylated in the control counterparts. Besides, calpain, a calcium dependent thiol protease present in the platelets, was found to remain active in this disease as reflected from the proteolysis of calpain substrates. Taken together, these data indicated abnormal circulating platelets in the patients of thrombotic stroke, which could contribute to the etiopathogenesis of this disease.
Similar content being viewed by others
References
Siess W: Molecular mechanism of platelet activation. Physiol Rev 69: 58–178, 1989
Liu L, Lin Z, Shen Z, Zhang G, Li S, Cao P: Platelets hyperfunction exists in both acute non-hemorrhagic and hemorrhagic stroke. Thromb Res 75: 485–490, 1994
Andrews RK, Lopez JA, Berndt MC: Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 29: 91–105, 1997
Bednar MM, Gross CE: Antiplatelet therapy in acute cerebral ischemia. Stroke 30: 887–893, 1999
Choudhri TF, Hoh BI, Zerwes HG, Prestigiacomo CJ, Kim SC, Conolly ES Jr, Kottirsch G, Pinsky DJ: Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GpIIb/IIIa receptor mediated platelet aggregation. J Clin Invest 102: 1301–1310, 1998
Murray JC, Kelly MA, Gorelick PB: Ticlopidine: A new antiplatelet agent for the secondary prevention of stroke. Clin Neuropharmacol 17: 23–31, 1994
Helgason CM, Bolin KM, Hoff JA, Winkler SR, Mangat A, Tortorice KL, Brace LD: Development of aspirin resistance in persons with previous ischemic stroke. Stroke 25: 2331–2336, 1994
Wu KK, Hoak JC: Spontaneous platelet aggregation in arterial insufficiency; mechanisms and applications. Thromb Haemost 30: 702–711, 1976
Van-Kooten F, Ciabattoni G, Patrono C, Schmitz PI, van-Gijn J, Koudstaal PJ: Evidence for episodic platelet activation in acute ischemic stroke. Stroke 25: 278–281, 1994
Van-Kooten F, Ciabattoni G, Koudstaal PJ, Dippel DW, Patrono C: Increased platelet activation in the chronic phase after cerebral ischemic and intracerebral hemorrhage. Stroke 30: 546–549, 1999
Wu G, Li F, Li P, Ruan C: Detection of plasma alpha granule membrane protein GMP-140 using radiolabelled monoclonal antibodies in thrombotic diseases. Haemostasis 23: 121–128, 1993
Grau AJ, Ruf A, Vogt A, Lichy C, Buggle F, Patscheke H, Hacke W: Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Hemost 80: 298–301, 1998
Anwaar I, Gottsater A, Ohlasson K, Mattiasson I, Lindgarde F: Increased levels of leukocyte derived inflammatory mediator in plasma and cAMP in platelets during follow up after acute cerebral ischemia. Cerebrovasc Dis 8: 310–317, 1998
Dash D, Rao GRK: Effects of propanolol on platelet signal transduction. Biochem J 309: 99–104, 1995
Dash D, Rao GRK: Characterization of the effects of propanolol on the physical state of platelet membrane. Arch Biochem Biophys 276: 343–347, 1990
Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929, 1962
Verhallen PFJ, Bevers EM, Cumifurius P, Zwaal RFA: Fluoride-dependent calcium-induced platelet procoagulant activity shows that calcium is involved in increased phospholipid transbilayer movement. Biochim Biophys Acta 942: 150–158, 1988
Dash D, Rao GRK, Somani PN, Das BK, Dube B: Physical microenvironment of platelet membrane in acute myocardial infarction. Ind J Biochem Biophys 27: 264–267, 1990
Kitagawa S, Nishitama H, Kametani F: Inhibition of ADP-induced aggregation of bovine platelet by saturated fatty acids and its relation with the changes of membrane surface changes. Biochim Biophys Acta 775: 197–202, 1984
Shattil SJ, Cooper RA: Membrane microviscosity and human platelet function. Biochemistry 15: 4832–4837, 1976
Chen RF, Bowman RL: Fluorescence polarization: Measurement with ultraviolet polarizing filters in a spectrophotofluorometer. Science 147: 729–732, 1965
Shinitzky M, Barenholz Y: Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 515: 367–394, 1978
Ferrell JE Jr, Martin GS: Platelet tyrosine specific protein phosphorylation is regulated by thrombin. Mol Cell Biol 8: 3603–3610, 1988
Nakamura SI, Yamamura H: Thrombin and collagen induce rapid phosphorylation of a common set of cellular proteins on tyrosine in human platelets. J Biol Chem 264: 7089–7091, 1989
Golden A, Brugge JS: Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. PNAS USA 86: 901–905 1989
Watson SP, Hambleton S: Phosphorylation-dependent and-independent pathways of platelet aggregation. Biochem J 258: 479–485, 1989
Shinitzky M, Barenholz Y: Dynamics of the hydrocarbon layer in liposomes of lecithin and sphingomyelin containing dicetylphosphate. J Biol Chem 249: 2652–2657, 1974
Watala C, Boncer M, Golanski J, Koziolkiewcz W, Trojanowski Z, Walkowiak B: Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitus. Eur J Haematol 61: 319–326, 1998
Nathan I, Fleischer G, Livne A, Dvilansky A, Parola AH: Membrane microenvironmental changes during activation of human blood platelets by thrombin. A study with fluorescent probe. J Biol Chem 254: 9822–9828, 1979
Koner BC, Jain M, Dash D: Platelets from eclampsia patients have reduced membrane microviscosity and lower activity of signaling enzymes. Int J Biochem Cell Biol 30: 147–154, 1998
Puddey IB, Burke V, Croft K, Beilin LJ: Increased blood pressure and changes in membrane lipids associated with chronic ethanol treatment of rats. Clin Exp Pharm Physiol 22: 655–657, 1995
Radda GK, Vanderkooi J: Can fluorescent probes tell us anything about membranes? Biochim Biophys Acta 265: 509–549, 1972
Clark EA, Shattil SJ, Brugge JS: Regulation of protein tyrosine kinases in platelets. Trends Biochem Sci 19: 464–469, 1994
Dhar A, Shukla SD: Tyrosine kinases in platelet signaling. Br J Haematol 84: 1–7, 1993
Feinstein MB, Pumiglia K, Lau LF: Tyrosine phosphorylation in platelets: Its regulation and possible roles in platelet function. In: K.S. Authi, S.P. Watson, V.V. Kakkar (eds). Mechanisms of Platelet Activation and Control. Plenum Press, New York, 1993, pp 129–148
Bachelot C, Cano E, Grelac F, Saleun S, Druker BJ, Levy-Toledano S, Fischer S, Rendu F: Functional implications of tyrosine phosphorylation in platelets. Biochem J 284: 923–928, 1992
Phillips DR, Jakabova M: Ca2+ dependent protease in human platelets. Specific cleavage of platelet polypeptide in the presence of added Ca2+. J Biol Chem 252: 5602–5605, 1977
Fox JE, Reynolds CC, Phillips DR: Calcium dependent proteolysis occurs during platelet aggregation. J Biol Chem 258: 9973–9981, 1983
Oda A, Drucker BJ, Ariyoshi H, Smith M, Salzman EW: pp60 src is an endogenous substrate for calpain in human blood platelets. J Biol Chem 268: 12603–12608, 1993
Cooray P, Yuan Y, Schoenwalder SM, Mitchell CA, Salem HH, Jackson SP: Focal adhesion kinase (pp125 FAK) cleavage and regulation by calpain. Biochem J 318: 41–47, 1996
Frangioni JV, Oda A, Smith M, Salznman EW, Neel BG: Calpain catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatases 1B (PTP-1B) in human platelets. EMBO J 12: 4843–4856, 1993
Falet H, Pain S, Rendu F: Tyrosine unphosphorylated platelet Shp-1 is a substrate for calpain. Biochem Biophys Res Commun 242: 51–55, 1998
Ishii H, Umeda F, Hashimoto T, Nawata H: Changes in phosphoinositide turnover Ca2+ mobilization and protein phosphorylation in platelets from NIDDM patients. Diabetes 39: 1561–1568, 1990
Fox JE, Reynolds CC, Austin CD: The role of calpain in stimulus response coupling: Evidence that calpain mediates agonist induced expression of procoagulant activity in platelets. Blood 76: 2510–2519, 1990
Schoenwaelder SM, Yuan Y, Jackson SP: Calpain regulation of integrin α,IIbβ3 signaling in human platelets. Platelet 11: 189–198, 2000
Shcherbina A, Kenney DM, Bretscher A, Remold-O'Donnell E: Dynamic association of moesin with the membrane skeleton of thrombinactivated platelets. Blood 93: 2128–2129, 1999
Schoenwaelder SM, Yuan Y, Cooray P, Salem HH, Jackson SP: Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin α,IIbβ3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. J Biol Chem 272: 1694–1702, 1997
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srivastava, K., Dash, D. Altered membrane fluidity and signal transduction in the platelets from patients of thrombotic stroke. Mol Cell Biochem 224, 143–149 (2001). https://doi.org/10.1023/A:1011979801366
Issue Date:
DOI: https://doi.org/10.1023/A:1011979801366